Home›Companies›Healthcare›Neuro42

Neuro42, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 16, 2024·Suggest an edit

About Neuro42

Neuro42 is a private company based in San Francisco, California, incorporated in 2020 in Delaware. It has reported $22,206,868 raised in two offerings on Form D since June 2024. Its chief executive is Amit Vohra.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 4, 2024Sep 16, 2024$15,551,687of $36.5M target85$182KEquityRule 506(b)Form D ↗
May 29, 2024Jun 11, 2024$6,655,181of $7.3M target24$277KEquityRule 506(b)Form D ↗
Total, two offerings$22,206,868

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Neuro42's Form D filed Sep 16, 2024.

KB
Amit Vohra
Amit Vohra
CEO and director
Also CEO and director at Promaxo and Promaxo.
RT
Rahul Talwar
Director
AB
Abhita Batra
Executive officer and director

Earlier filings also listed Shibu Gangadharan (executive officer, last listed Jun 2024).

Sources

  1. SECNeuro42, Inc. filing history